A rectal cancer model establishes a platform to study individual responses to chemoradiation
暂无分享,去创建一个
Hans Clevers | Lukas E. Dow | Jinru Shia | Maha Shady | Ronald P. DeMatteo | Scott W. Lowe | Afsar Barlas | Seo-Hyun Choi | M. Berger | S. Lowe | J. Massagué | H. Clevers | K. Manova-Todorova | J. Guillem | G. Nash | M. Weiser | C. Sawyers | L. Saltz | R. Yaeger | R. DeMatteo | H. Won | A. Cercek | Raphael A. Pelossof | Seo-Hyun Choi | P. Paty | R. Kolesnick | W. Karthaus | Ching-Tung Chen | J. Shia | I. Wei | Jennifer W. Harris | J. Garcia-Aguilar | J. J. Smith | L. Dow | Maha Shady | Joan Massagué | Charles L. Sawyers | Wouter R. Karthaus | K. O’Rourke | Julio Garcia-Aguilar | Andrea Cercek | Chin-Tung Chen | M. Adileh | P. Romesser | Martin R. Weiser | Youyun Zheng | A. Barlas | Michael Berger | Helen H. Won | Leonard B. Saltz | Emmanouil Pappou | Paul B. Romesser | Kevin P. O’Rourke | I. Wasserman | Jennifer W Harris | Karuna Ganesh | Chao Wu | Mohammad Adileh | Bryan C. Szeglin | Isaac Wasserman | Michael R. Marco | Youyun Zheng | Arthur Elghouayel | James S. Strong | Garrett M. Nash | Jose G. Guillem | Iris H. Wei | Richard N. Kolesnick | Katia O. Manova-Todorova | Philip B. Paty | Rona D. Yaeger | J. Joshua Smith | Bryan C Szeglin | James S Strong | Chao Wu | E. Pappou | K. Ganesh | Arthur Elghouayel | J. Smith | Arthur E. Elghouayel | J. García-Aguilar
[1] J. BotellaLlusiá,et al. [Long-term results]. , 1983, Anales de la Real Academia Nacional de Medicina.
[2] R. Scott,et al. Long-Term Results , 2001 .
[3] P. Rothberg,et al. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. , 1988, Oncogene.
[4] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[5] E. Gamelin,et al. Relationship between 5‐fluorouracil (5‐FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5‐FU , 1996, Cancer.
[6] Fábio Guilherme Campos,et al. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.
[7] Jerilyn A. Walker,et al. Quantitative PCR for DNA identification based on genome-specific interspersed repetitive elements. , 2004, Genomics.
[8] E. Van Cutsem,et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. , 2009, The New England journal of medicine.
[9] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[10] Karin Haustermans,et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. , 2010, The Lancet. Oncology.
[11] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[12] D. Thal. The role of astrocytes in amyloid β-protein toxicity and clearance , 2012, Experimental Neurology.
[13] Sunil Krishnan,et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Torsten Hothorn,et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. , 2012, The Lancet. Oncology.
[15] K. Goodman,et al. Pulmonary Recurrence Predominates After Combined Modality Therapy for Rectal Cancer: An Original Retrospective Study , 2012, Annals of surgery.
[16] A. Günther,et al. a pilot trial , 2012 .
[17] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[18] Laura B. Kleiman,et al. Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers , 2013, PloS one.
[19] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[20] T. Nomiya. Discussions on target theory: past and present , 2013, Journal of radiation research.
[21] K. Goodman,et al. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.
[22] M. Gonen,et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[24] J. Garcia-Aguilar,et al. Advances and challenges in treatment of locally advanced rectal cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] K. Manova-Todorova,et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection , 2015, Scientific Reports.
[26] Hans Clevers,et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases , 2015, Proceedings of the National Academy of Sciences.
[27] R. Beart,et al. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. , 2015, Journal of the National Cancer Institute.
[28] Hans Clevers,et al. Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer , 2015, Cell.
[29] Hayley E. Francies,et al. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.
[30] V. Seshan,et al. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.
[31] L. Stassen,et al. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer. , 2016, Journal of the National Cancer Institute.
[32] H. Yin,et al. Evaluation of Hydrogel Suppositories for Delivery of 5-Aminolevulinic Acid and Hematoporphyrin Monomethyl Ether to Rectal Tumors , 2016, Molecules.
[33] Donavan T. Cheng,et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.
[34] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[35] A. Jemal,et al. Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[36] T. Beißbarth,et al. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling , 2017, Molecular Cancer Research.
[37] Francisco J. Sánchez-Rivera,et al. In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.
[38] E. R. van den Heuvel,et al. Survival analysis of the CEAwatch multicentre clustered randomized trial , 2017, The British journal of surgery.
[39] H. Abe,et al. Highly sensitive and specific Alu-based quantification of human cells among rodent cells , 2017, Scientific Reports.
[40] Teng Han,et al. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer , 2017, Nature Biotechnology.
[41] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[42] Andrea Sottoriva,et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.
[43] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[44] Hans Clevers,et al. Intra-tumour diversification in colorectal cancer at the single-cell level , 2018, Nature.
[45] M. Gonen,et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome , 2017, JAMA oncology.
[46] Charles R. Thomas,et al. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited‐stage small cell lung cancer in elderly patients versus younger patients , 2018, Cancer.